Severe clinical toxicities are correlated with survival in patients with ... - UroToday PDF Print

Severe clinical toxicities are correlated with survival in patients with ...
UroToday
BACKGROUND: In advanced renal cell carcinoma (RCC), sunitinib and sorafenib tyrosine kinase inhibitors (TKI) are associated with several clinical side effects, with no definitive established data concerning their clinical impact.

...

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.